Oculis Holding AG (OCS) Price to Earnings (2021 - 2026)

Oculis Holding AG (OCS) Price to Earnings (2021 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	P/E
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-32.10 Bn
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-70,009.43
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	918.78
4	NuCana	279.75 Bn	279.75 Bn	-	-379.65
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	27.71
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	15.33
7	Belite Bio	62.51 Bn	62.51 Bn	-	367.72 Bn
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	38.55
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-27.26
10	Alnylam Pharmaceuticals	35.71 Bn	32.70 Bn	959.66 Mn	65.66

Download Data